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Abstract: A new approach to in vivo biosensor design is introduced, based 
on the use of an implantable micron-sized retroreflector-based platform and 
non-invasive imaging of its surface reflectivity by Optical Coherence 
Tomography (OCT). The possibility of using OCT for the depth-resolved 
imaging and detection of micro-retroreflectors in highly turbid media, 
including tissue, is demonstrated. The maximum imaging depth for the 
detection of the micro-retroreflector-based platform within the surrounding 
media was found to be 0.91 mm for porcine tissue and 1.65 mm for whole 
milk. With further development, it may be possible to utilize OCT and 
micro-retroreflectors as a tool for continuous monitoring of analytes in the 
subcutaneous tissue. 
© 2010 Optics Society of America 
OCIS codes: (110.4500) Optical coherence tomography; (170.4500) Optical coherence 
tomography; (170.4580) Optical diagnostics for medicine; (280.4788) Optical sensing and 
sensors. 
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1. Introduction 
A broad range of biosensors are used today in clinical applications, ranging from glucose 
monitoring in diabetic patients [1–6], to pathogen detection [7,8], and to drug and toxic 
metabolite detection in tissues [9–12]. Most applications do not require recurrent monitoring 
of specific analytes, and these measurements can be performed in vitro. However for 
monitoring of, e.g., glucose levels, it is desirable to make frequent (or even continuous) 
measurements. A practice recommended by the American Diabetes Association for diabetic 
patient evaluation is to monitor blood glucose levels 3-4 times daily for type I diabetics and 
once each day for type II diabetics [13]. Such monitoring can be difficult and uncomfortable 
for the patient because most methods for monitoring blood glucose levels require puncturing 
of the skin. Thus, it is important to develop alternate approaches that would make it easier and 
less painful for patients to monitor frequently their vital analytes. 
Usually, biosensors require contact between an analyte-sensitive biological element and 
the tissue for the creation of a measurable signal. The development of implantable biosensors 
can avoid the aforementioned disadvantage of skin puncturing by providing potentially non-
invasive monitoring of the analyte of interest. A sub-millimeter-sized implantable biosensor 
platform can be placed within the hypodermis (the subcutaneous tissue), which would 
minimize the discomfort associated with daily readings. Utilizing such small implantable 
biosensors in the subcutaneous tissue would allow access to the dermis and sub-dermis tissue 
layers, which contain many analytes of interest (e.g., glucose). 
#130861 - $15.00 USD Received 29 Jun 2010; revised 23 Jul 2010; accepted 23 Jul 2010; published 2 Aug 2010
(C) 2010 OSA 1 September 2010 / Vol. 1,  No. 2 / BIOMEDICAL OPTICS EXPRESS  368
For glucose monitoring, many research efforts have been focused on the Concanavalin A 
(ConA)-dextran system which, unlike glucose-oxidase-based sensors, is independent of local 
oxygen levels [14–16]. For our envisioned retroreflector-based biosensor, we plan to 
immobilize ConA or other glucose binding agents, such as boronate, onto the implantable 
biosensor surface and allow dextran-coated gold nanoparticles to assemble onto the biosensor 
surface. The presence of glucose will induce the dissociation of the dextran-coated gold 
nanoparticles from the ConA-coated surface and increase reflectivity of the surface. More 
importantly, changes in glucose levels will induce changes in the reflectivity of the biosensor 
surface due to the light scattering caused by the presence of gold nanoparticles. In this 
approach, an imaging technique must be used that is capable of resolving retroreflectors 
implanted in subcutaneous tissue, and reliably measuring the reflectivity of the biosensor 
surface, which signals the glucose concentration. 
Towards this goal, we have recently developed a highly reflective, micro-retroreflector-
based substrate as a platform for the biosensor. This design includes an array of micron-sized 
retroreflectors (micro-retroreflectors) fabricated on a silicon substrate. Retroreflectors are 
unlike planar mirrors, which only return maximum light directly back to the source if the 
mirror is perpendicular to the wave front. In contrast, retroreflectors reflect incident light in an 
anti-parallel manner directly back to its source for a wide range of angles without the need for 
precise alignment. Retroreflectors exist in the form of linear retroreflectors, prisms (or corner 
cubes), spheres, and cat’s eye retroreflectors [17–22], most of which have to date only been 
fabricated in the form of reflective sheets for use in road signs, vehicle reflectors, and safety 
clothing. For this study, simple linear micro-retroreflectors were used, as schematically shown 
in Fig. 1. 
 
Fig. 1. Linear micro-retroreflector: two reflecting surfaces where incident light is always 
directed back to the source in an anti-parallel manner. 
Development of the biosensor platform requires an imaging technique capable of receiving 
depth-resolved reflections from the micro-retroreflector-based platform surface as well as 
achieving high spatial resolution for detection of multiple micro-retroreflectors in tissue. 
Conventional imaging modalities such as magnetic resonance imaging, ultrasound, and X-ray 
imaging are capable of imaging structures within tissue, but these modalities lack the high 
spatial resolution and/or potential analyte-responsiveness required for our application of 
detecting micro-retroreflectors within tissue. 
In this study, therefore, we investigated the use of Optical Coherence Tomography (OCT) 
[23], a non-invasive and depth-resolved imaging technique, for reflectance measurements of 
micro-retroreflectors in the subcutaneous tissue. OCT has high transverse resolution (<10 
µm), which allows for the visualization of individual micro-retroreflectors in tissue, high SNR 
(up to 120 dB) for the precise detection of optical signals when returning from tissue, high in-
depth resolution (~10 µm), and several millimeters of depth penetration in order to image 
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through the stratum corneum and epidermis layers of the skin. In conventional OCT, a two-
beam interferometer is used to obtain depth-profiled information on the sample of interest 
within the coherence length of the laser. A beam from a broadband low-coherence laser 
source is split into the reference and sample arms of the interferometer. The backscattered 
light from the sample is recombined with the back-reflected light from the reference arm, 
resulting in the formation of interference fringes, which are captured by an optical sensor. 
OCT methods can be divided into two classes, Time Domain (TD-OCT) and Fourier Domain 
(FD-OCT), which is further split into Swept Source OCT (SS-OCT) and Spectral Domain 
OCT (SD-OCT). In TD-OCT, a scanning reference arm mirror is used, whereas in FD-OCT 
the reference arm mirror is fixed. In SD-OCT, a broadband laser source, and a spectrometer 
with a line camera are used, while in SS-OCT, a swept laser source and photodetector(s) are 
used. In SS-OCT, an in-depth profile (1D, known as an A-scan) of the sample is obtained by 
performing discrete Fourier transform on the acquired fringes recorded by the 
photodetector(s). Galvanometer mirrors added to the sample arm can be used to construct 2D 
(B-scan) and 3D (C-scan) images of the sample. 
The optical properties of skin can vary significantly among individuals and over time, 
posing a challenge for absolute analyte level measurements. Thus, for the envisioned 
implantable glucose sensing biosensor, the micro-retroreflector-based platform must be self-
calibrating. For example, one micro-retroreflector can be an analyte-responsive assay reflector 
while the remaining surrounding micro-retroreflectors can act as “always-on” reference 
reflectors, allowing for accurate determination of reflectivity reduction. Another requirement 
for the prospective implantable glucose sensing biosensor is the ability to detect and measure 
the signal in an automated regime. The unique and complex micro-retroreflector structures 
can act as an easily recognizable pattern when submerged in tissue. This approach will 
significantly simplify the future development of home products for blood glucose 
measurements. 
In this paper, we report the first phase of creating such a biosensor that includes the 
development of the implantable solid platform, the employment of an imaging modality to 
detect and visualize the entire retroreflector pattern, and to monitor its reflectance in varying 
depths of highly scattering media, such as skin. For future phases of this study, we plan to 
integrate the necessary chemistry for the detection of specific analytes, such as glucose. 
2. Materials and methods 
2.1 Experimental setup 
Figure 2 shows a schematic of a customized swept-source OCT (SS-OCT) system used in this 
study (based on Thorlabs SL1325, Newton, New Jersey, USA). A broadband swept-source 
laser with a wavelength of 1325 ± 50 nm and an output power of 12 mW was used as the 
optical source in this system. The A-line scanning rate was 16 kHz. The SS-OCT system was 
based on a Mach-Zehnder interferometer (MZI) where 10% of the power was directed to the 
reference arm and 90% to the sample arm. The interference fringes were detected by a 
balanced photodetector (Thorlabs PDB140C), which was used to remove the common mode 
noise, digitized using a 14-bit ADC (AlazarTech ATS460), and recalibrated using an MZI 
clock signal (MZI, Thorlabs INT-MZI-1300), which provided a frequency clock for the laser. 
The acquired images were 512 × 512 pixels. In-depth scanning was up to 3 mm (in air), while 
lateral scanning varied from 0.5 to 2 mm. The system’s measured axial and transverse 
resolution were ~12 µm and ~15 µm (in air), respectively. 
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 Fig. 2. The schematic outline of the SS-OCT system used in this study (ADC: analog to digital 
converter; MZI: Mach Zehnder interferometer). 
2.2 Micro-retroreflectors 
Linear micro-retroreflector arrays were fabricated as follows. A silicon wafer was coated with 
a 5 µm layer of polyimide, a 300 nm layer of poly(methyl glutarimide) (PMGI), and a 200 nm 
layer of poly(methyl-methacrylate) (PMMA) by spin-casting. The top PMMA layer was then 
exposed using electron beam lithography in the pattern of the retroreflectors, developed for 30 
seconds in a 3:1 solution of isopropanol and methylisobutylketone, and rinsed in isopropanol. 
The PMGI layer was then etched in a 2.3% solution of tetramethyl ammonium hydroxide in 
water and a thin coating of nickel was then thermally evaporated onto the wafer surface. A 
lift-off step then dissolved the PMMA leaving only the nickel deposited in the resist openings. 
This pattern was further transferred into the polyimide by a directional oxygen reactive-ion 
etch. Finally, the entire structure was coated with a layer of gold. These structures were 
imaged with Scanning Electron Microscopy (SEM), and are shown in Fig. 3. 
Micro-retroreflectors were 5 µm tall, 10 µm wide and 50 µm long. These linear micro-
retroreflectors were designed to reflect light incident from any angle back to the source in an 
anti-parallel manner. The degree of alignment for linear micro-retroreflectors lies in one 
angular dimension, as shown in Fig. 1. 
 
Fig. 3. SEM images of micro-retroreflector structures. 
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2.3 Sample preparation 
Whole milk (with 3.7% fat content) and fresh porcine skin were used for testing SS-OCT 
imaging of micro-retroreflectors as a function of the scattering media depth. Porcine skin was 
purchased from the local market. Small skin samples (0.5 × 0.5 cm2) were excised from the 
porcine ear and placed in a saline bath. The samples were kept hydrated while covering the 
micro-retroreflectors during SS-OCT imaging, and each sample was used only once. 
3. Results 
A silicon wafer containing gold micro-retroreflectors was mounted on top of a dual-axis 
rotating stage, which was further connected to a 2D-translational stage for 3D positioning. 
The focused incident light beam from the SS-OCT setup was directed onto the micro-
retroreflectors and scanned over a 1 × 1 mm2 area, an area sufficient for imaging the full 
micro-retroreflector array. At a 65° tilt angle, which provided maximum reflectivity for the 
fabricated micro-retroreflectors, 3D sample volumes were recorded by SS-OCT and 
reconstructed using LabVIEW and Thorlabs Swept 3D Viewer software. For each 3D volume, 
multiple rows of micro-retroreflectors were averaged together to create one 1D micro-
retroreflector intensity profile. Figure 4A shows an example of a recorded 3D volume of 
micro-retroreflectors in air obtained after reconstruction of SS-OCT data, and Fig. 4B displays 
the average intensity profiles obtained within this 3D volume. The average intensity profile 
shown in Fig. 4B was constructed by averaging together each individual row of micro-
retroreflectors displayed in Fig. 4A. B-scans were extracted from each 3D volume and peak 
analysis was performed. The retroreflectors were oriented with the scanning OCT beam such 
that scanning occurred parallel to the retroreflectors. This regime ensured the highest 
probability of equivalent reflectivity for all micro-retroreflectors. 
To investigate the ability of SS-OCT to detect the entire micro-retroreflector pattern 
within scattering media as a function of depth, two sets of experiments were performed: one 
with whole milk and the other with porcine skin. In the first set of experiments, 21 different 
volumes of whole milk (with 3.7% fat content) were deposited, dropwise, on top of the micro-
retroreflector array to provide different thicknesses of scattering medium. To prevent milk 
spillage, a plastic dam was designed and placed on the silicon wafer with adhesive glue. The 
varied depths of whole milk (refractive index, n = 1.35 [24], ) were determined optically by 
SS-OCT after performing the experiments. Figure 5 represents typical one-dimensional micro-
retroreflector intensity profiles for a selected set of samples with thicknesses ranging from 
0.10 mm to 1.65 mm. 
 
Fig. 4. (A) 3D volume (0.7 mm × 0.7 mm × 3 mm) of micro-retroreflectors in air obtained by 
SS-OCT with row indexing; (B) an averaged intensity profile of micro-retroreflectors in air 
(corresponding to an averaging through rows 1-5 of the micro-retroreflectors shown in A). 
As expected, with an increase in sample depth the contrast between micro-retroreflectors 
and the background medium begins to decrease. Below the depth of 1.65 mm some micro-
#130861 - $15.00 USD Received 29 Jun 2010; revised 23 Jul 2010; accepted 23 Jul 2010; published 2 Aug 2010
(C) 2010 OSA 1 September 2010 / Vol. 1,  No. 2 / BIOMEDICAL OPTICS EXPRESS  372
retroreflectors become undetectable by SS-OCT, thereby, breaking the integrity of the entire 
platform pattern. One can see from this figure irregularities in uniformity of the selected peaks 
as the sample depth increases. This observation can be explained by the presence of 
inhomogeneities in whole milk, such as aggregates of fat globules and of protein particles 
[24]. Similar results were obtained for the remaining sets of samples, and are summarized in 
Fig. 6. 
In the second set of experiments, a 0.5 × 0.5 cm2 section of porcine skin was excised from 
porcine ear and placed in a saline bath to prevent dehydration and to preserve natural 
physiological conditions; 27 samples with thicknesses varying from 0.29 mm to 0.91 mm 
were used. Porcine tissue thicknesses were determined optically from SS-OCT images using 
the known refractive index (n = 1.45 [25], ). Each sample was placed on top of the micro-
retroreflectors, and 2D and 3D SS-OCT data sets were recorded. Figure 7 shows the micro-
retroreflector intensity profiles for porcine tissue depths of 0.31 mm, 0.34 mm, 0.49 mm, 0.59 
mm, 0.61 mm, and 0.80 mm. 
In the case of porcine skin, below the depth of 0.91 mm some micro-retroreflectors 
become undetectable by SS-OCT. Figure 8 summarizes the contrast between micro-
retroreflectors and porcine tissue for all samples studied in these experiments. 
4. Discussion 
The obtained results demonstrate the capability of SS-OCT to detect micro-retroreflectors 
within highly scattering media, such as whole milk and tissue, at depths up to at least 1.65 
mm. With an increase in scattering media depth, the signal returning from the micro-
retroreflectors decreases due to the attenuation of the photons. This reduces the contrast 
between the micro-retroreflectors and surrounding media. Here, we define contrast as the 
signal difference between micro-retroreflectors and media, excluding reflections returning 
from tissue inhomogeneities, when the entire platform pattern remains fully visible. The 
background signal (scattered photons from surrounding media) was averaged and subtracted 
from an averaged signal from the micro-retroreflector surface, which decreases with depth 
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 Fig. 5. Intensity profiles of micro-retroreflectors beneath varying depths of whole milk. 
Estimated dB contrast is shown in upper right corner of each pane. The 3D SS-OCT volumes 
(1 mm × 1 mm × 3 mm) on the right shows micro-retroreflectors beneath 0.53 mm and 0.84 
mm of whole milk. 
 
Fig. 6. Micro-retroreflector–milk contrast beneath varying depths of whole milk. 
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 Fig. 7. Intensity profiles of micro-retroreflectors beneath varying thicknesses of porcine tissue. 
Estimated dB contrast is shown in upper right corner of each pane. The 3D SS-OCT volumes 
(1 mm × 1 mm × 3 mm) on the right show micro-retroreflectors beneath 0.34 mm and 0.49 mm 
of porcine tissue. 
 
Fig. 8. Micro-retroreflector – tissue contrast beneath varying thicknesses of porcine tissue. 
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due to attenuation. A minimum level of contrast seen in this study was detected to be 15 ± 3.4 
dB for whole milk and 20 ± 6.4 dB for porcine tissue. Below these levels, the micro-
retroreflector structures were obstructed by tissue inhomogeneities. A maximum penetration 
depth of 2 mm for whole milk and 1.15 mm for porcine tissue was estimated by allowing the 
linear fit line in Fig. 6 and Fig. 8 to intercept the abscissa axis (where the contrast is close to 0 
dB). From previous studies employing an analogous OCT setup it has been shown that 
approximate penetration depths achievable for porcine tissue is about 1 mm, which is in good 
accordance with our results [26]. 
Optical properties are different for homogeneous and heterogeneous media, and contrast 
between the micro-retroreflectors and surrounding media can vary greatly depending on the 
scattering nature of the media. Biological tissue can be described optically as a spatial 
distribution of refractive indices on the microscopic scale [27,28]. The local refractive index 
within the tissue can range from 1.34 to 1.50, depending on the type of biological tissue. This 
variation (mismatch) of refractive index distribution within the tissue can cause strong light 
scattering. On the other hand, whole milk can be described as a homogenous solution of 
scattering centers (fat aggregates and protein aggregates) with sizes ranging from the 
nanometer to sub-micrometer scale [24]. In contrast to whole milk, porcine tissue has a highly 
reflective rough surface and vast heterogeneity (tissue structures ranging from the micrometer 
to sub-millimeter scale) [26]. The necessity to maintain contrast above a certain level in order 
to distinguish the entire micro-retroreflector pattern from surrounding media reduces the 
maximum depth within which the micro-retroreflectors can be placed in different scattering 
media. 
Overall, these results reveal the operational depths and potential contrast (micro-
retroreflector – tissue) for the micro-retroreflector-based platform immersed in scattering 
media, such as biological tissue. It is important to reiterate that the operational depths for the 
envisioned platform are less than the known penetration depths achievable by OCT, due to 
necessity to provide complete pattern visibility. This therefore makes our work essential for 
understanding the depths at which the entire micro-retroreflector-based platform can be placed 
in highly scattering media before reflections are lost, which is necessary for the future 
development of micro-retroreflector based technologies that operate in the dermis tissue layer. 
5. Conclusion 
Our experimental results demonstrate the possibility of using OCT for the depth-resolved 
imaging and detection of micro-retroreflectors in skin, at depths reaching the 
dermis/subcutaneous fat layers. For this study, micro-retroreflectors were chosen because of 
their ability to direct incident light back to the detector in an anti-parallel manner. Incident 
light not directed onto the micro-retroreflectors will scatter in all directions with negligible 
amounts returning to the detector, thereby allowing for contrast to develop between the micro-
retroreflectors and scattering medium. This characteristic makes imaging flat gold mirrors 
challenging, where it is required that the incident light beam be perpendicular to the sample 
surface in order to obtain maximal reflections. We have shown that the proposed micro-
retroreflector-based platform can be detected with OCT at depths reaching 1.65 mm in whole 
milk and 0.91 mm in porcine tissue, which is generally less than maximum penetration depths 
achievable by OCT. This difference in depth is due to the necessity to provide sufficient 
contrast between the micro-retroreflector-based platform and surrounding scattering media. 
The minimum contrast was found to be 15 ± 3.4 dB for whole milk and 20 ± 6.4 dB for 
porcine tissue. High levels of minimum contrast for porcine tissue and whole milk are 
suggested to exist due to the presence of inhomogeneities in biological samples, which can 
obstruct the reflectivity of micro-retroreflector surfaces at greater depths. With further 
development of this assay platform, it may be possible to utilize OCT and micro-
retroreflectors as a tool for monitoring glucose levels and other analytes in subcutaneous 
tissue environments by decorating the micro-retroreflector surface with chemical compounds 
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selectivity sensitive to certain analytes, which can then alter surface reflectivity due to 
changes in analyte concentration. 
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